Viewing Study NCT00101803


Ignite Creation Date: 2025-12-24 @ 7:44 PM
Ignite Modification Date: 2025-12-28 @ 11:32 PM
Study NCT ID: NCT00101803
Status: COMPLETED
Last Update Posted: 2017-05-17
First Post: 2005-01-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Drug Naive Patients With Type 2 Diabetes
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module